期刊文献+

加强循证医学研究,进一步优化心房颤动治疗策略 被引量:5

Enhance the study of evidence-based medicine to optimize the therapeutic strategy of atrial fibrillation
原文传递
导出
摘要 心房颤动(房颤)的治疗包括多种方法,目前药物治疗仍是应用最广的手段,非药物治疗,如经导管射频消融发展迅速,外科微创迷宫术、植入性心房除颤器、起搏治疗也在研究、探索之中。虽然房颤治疗手段多样,但如何选择仍然是困扰临床医师的问题之一。
作者 黄从新
出处 《中华心律失常学杂志》 2008年第4期245-246,共2页 Chinese Journal of Cardiac Arrhythmias
  • 相关文献

参考文献13

  • 1Nichol G,McAlister F,Pham B,et al. Meta-analysis of randomised controlled trials of the effectiveness of antiarrhythmic agents at promoting sinus rhythm in patients with atrial fibrillation. Heart, 2002,87:535-543.
  • 2AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation : an AFFIRM substudy of the first antiarrhythmic drug. J Am Coil Cardiol, 2003,42 : 20-29.
  • 3Haissaguerre M, Shah DC, Jais P, et al. Etectrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation, 2001,102:2463-2465.
  • 4Pappone C, Rosanio S, Oreto G,et al. Circumferential ablation of pulmonary vein ostia. A new anatomic approach for curing atrial fibrillation. Circulation,2000,102 : 2619-2628.
  • 5Hocini M, Jais P, Sanders P, et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation, 2005,112 : 3688-3696.
  • 6Nademanee K,Schwab M,Porath J,et al. How to perform electrogram-guided atrial fibrillation ablation. Heart Rhythm, 2006,3 : 981-984.
  • 7Pappone C,Santinelli V,Manguso F,et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation,2004,109:327-334.
  • 8Raitt MH, Volgman AS,Zoble RG, et al. Prediction of the recurrence of atrial fibrillation after cardioversion in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Am Heart J,2006,151 : 390-396.
  • 9Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation ,2005,111 : 1100-1105.
  • 10黄从新,张澍,马长生,曹克将,杨延宗,刘旭,刘少稳,马坚,吴书林,江洪,黄德嘉,王方正,陈新.中国经导管消融治疗心房颤动注册研究[J].中华心律失常学杂志,2006,10(6):468-474. 被引量:29

二级参考文献4

共引文献28

同被引文献47

  • 1杨延宗,黄从新,高连君,刘少稳,杨东辉,林治湖.阵发性心房颤动大静脉电隔离后肌袖内自发电活动的特点[J].中华心律失常学杂志,2004,8(3):146-150. 被引量:20
  • 2肖华,廖玉华.循证医学与靶向治疗——心血管病治疗前沿领域的辩证思考[J].医学与哲学(B),2007,28(1):1-3. 被引量:1
  • 3Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibriUation [ J ]. Circulation,2007,115:2689-2696.
  • 4AFFIRM. First antiarrhythmic drug substudy investigators main-tenance of sinus rhythm in patients with atrial fibrillation: an AF-FIRM substudy of the first antiarrhythmic drug. Jamcoll Cardiol, 2003, 42: 20-29.
  • 5Lasala JM, Mehran R, Moses JW, et al. Evidence based management of patients undergoing PCI. Conclusion [J 1. Catheter Cardiovasc Interv, 2010, 75(Suppl 1): 43-45.
  • 6McNutt RA, Livingston EH, McNutt RA, et al. Evidence- based medicine requires appropriate clinical context[J]. JAMA, 2010, 303(5): 454-455.
  • 7Graham I, Atar D, Borch Johnsen K, etal. European guidelines on cardiovascular disease prevention in clinical practice: executive summary[J]. Atherosclerosis, 2007, 194(1): 1-45.
  • 8Pappone C, Augello G, Santinelli V. Atrial fibrillation ablation [ J ]. Ital Heart J,2005,6 : 190-199.
  • 9Mandapati R, Skanes A, Chen J, et al. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart[ J ]. Circulation, 2000,101:194-199.
  • 10Yang Y, Mangat I, Glatter KA, et al. Mechanism of conversion of atypical right atrial flutter to atrial fibrillation [ J ]. Am J Cardiol,2003 ,91:46-52.

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部